TRENTON, NJ – In a response to the U.S. Supreme Court’s recent ruling in FDA v. Alliance for Hippocratic Medicine & Danco Laboratories v. Alliance for Hippocratic Medicine, New Jersey’s acting Governor, Lieutenant Governor Way, praised the decision for safeguarding access to essential medications for women across the United States. This statement follows critiques from New Jersey Senator Cory Booker, who has characterized the Supreme Court as partisan and conservative.
Lieutenant Governor Way emphasized the importance of the ruling, noting that mifepristone has been safely used by millions of women for decades to manage pregnancies and miscarriages. She highlighted that the decision is crucial in ensuring that the rights of women to make autonomous healthcare decisions are not compromised by extremist views.
In the wake of the controversial Dobbs decision in 2022, which significantly impacted abortion rights in several states, Lieutenant Governor Way reassured that New Jersey remains committed to protecting and enhancing reproductive freedoms. She expressed hope for a future where all women in the country have the unequivocal right to choose, reflecting an ongoing commitment to accessible and safe healthcare for women.
